News | August 09, 2010

Researchers Say New Protocol May Lower CT Dose by Nearly 50 Percent

August 9, 2010 - Researchers at Mayo Clinic are working to reduce radiation dosages used to acquire perfusion and other CT images.

The As Low As Reasonably Achievable, or ALARA, principle has always guided Mayo Clinic’s approach to the dosages of radiation used to acquire CT images. Dr. McCollough’s team has been experimenting with a newly created image-processing algorithm that produces high-quality perfusion CTs with up to 20 times less the radiation used under existing protocols.

“We believe in the clinical value of perfusion CT, and though there is no documented risk of injury at the currently prescribed radiation levels, we are trying to lower the dose for the benefit of patients,” said Cynthia McCollough, diagnostic radiologist, Mayo Clinic.

Depending on the diagnostic application, a perfusion CT exam takes about 30 seconds to scan the tissue multiple times after iodine has been injected. This technique detects changes in blood volume and flow that reveal injuries to vessels or a tumor’s response to treatment. Information from each consecutive scan is then digitally cross-referenced with other images taken during the exam to improve image quality and reduce distortions.

McCollough, Ph.D., and her group of researchers presented their findings related to CT dose reduction at the 52nd Annual Meeting of the American Association of Physicists in Medicine on July 20 in Philadelphia. The presentation was entitled “20-Fold Dose Reduction Using a Gradient Adaptive Bilateral Filter: Demonstration Using in Vivo Animal Perfusion CT.”

Thus far, the new perfusion CT algorithms have proved effective in animal models, and Dr. McCollough’s team has begun looking at ways to introduce the methodologies into clinical practice.

“When we use very low doses of radiation to acquire a CT, image graininess can significantly decrease the value of the exam,” says the study’s first author, Juan Carlos Ramirez Giraldo, Mayo Clinic. “With this new algorithm, we are able to maintain the image quality by cross-referencing it with other images collected during the exam.”

In related efforts, a team of radiologists and physicists have recently implemented a new routine head CT protocol that cuts radiation dose by nearly 50 percent. While the American College of Radiology allows its accredited facilities to use head CT doses up to approximately 75 mGy, Mayo Clinic’s newly introduced patient protocol uses a dose of only 38 mGy. This dose reduction is particularly significant as head CT exams are one of the most commonly performed CT procedures.

When asked how the new head CT protocol is changing clinical practice, neuroradiologist David DeLone, M.D., Mayo Clinic, says, “patients aren’t aware that anything has changed, and as radiologists looking at a study, we don’t know anything has changed. Yet, we are obtaining high-quality images, more consistently and in shorter times, while exposing patients to about half of the radiation dose. It’s a win-win for everyone.”

For more information: www.mayo.edu

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init